idiopathic thrombocytopenic purpura

(redirected from immune thrombocytopenic purpura)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

idiopathic thrombocytopenic purpura

[¦id·ē·ə¦path·ik ¦thräm·bō‚sīd·ə′pē·nik ′pər·pyə·rə]
(medicine)
Thrombocytopenic purpura of unknown causes.
References in periodicals archive ?
Childhood Immune thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of International Working Group on Immune Thrombocytopenic Purpura. Turk J Haematol.
Low rate of longlasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Jubelirer, "Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura," American Journal of Hematology, vol.
Immune thrombocytopenic purpura with bleeding manifestations in a case of borderline lepromatous leprosy on multidrug therapy (MDT) for 6 months, has been reported.
Immune thrombocytopenic purpura (ITP) is an immune-mediated disease characterised by thrombocytopenia, the degree of which determines the increased risk of bleeding.
A 8-year-old girl with immune thrombocytopenic purpura (ITP) who had ecchymoses on the body and a history of falling in the school was diagnosed as physical abuse as a result of evaluation by the departments of pediatric psychiatry and forensic medicine.
When the first attack is thrombocytopenia you have to diagnose it as immune thrombocytopenic purpura because at that moment you do not know that this patient will also develop an autoimmune hemolytic anemia attack.
anti-D increases the platelet count more rapidly and for a longer period of time than 50 [micro]g/Kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001; 112:1076-1078.
It promotes and supports the general welfare of patients, and the families of patients, with immune thrombocytopenic purpura (ITP).
Coronary artery bypass grafting in immune thrombocytopenic purpura. Ann Thorac Surg 1997; 64:1059-62.
Rozrolimupab (Sym001) is currently in phase II clinical development as a treatment of immune thrombocytopenic purpura (ITP) and as anti-D prophylaxis (ADP) to prevent hemolytic disease of the newborn (HDN).
Immune thrombocytopenic purpura is diagnosed by excluding other conditions which cause thrombocytopenia such as cancer or medications, including heparin or sulfonamides (Sandler, 2010).